Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Satlin
Weill Medical College of Cornell University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California San Fransisco Medical Center
San Francisco, California, United States
- Hackensack Meridian Health
Nutley, New Jersey, United States
- Mount Sinai Hospital
New York, New York, United States
- University of North Carolina Chapel Hill
Chapel Hill, North Carolina, United States
- Oregon Health and Science University
Portland, Oregon, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Mar 2021
- Primary completion
- 30 Dec 2021
- Completion
- 28 Feb 2022
- Last update posted
- 6 Apr 2022
- Registered enrollment
- 168
- Registry id
- NCT04710212
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.